These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Lufft V; Hoogestraat-Lufft L; Fels LM; Egbeyong-Baiyee D; Tusch G; Galanski M; Olbricht CJ Am J Kidney Dis; 2002 Aug; 40(2):236-42. PubMed ID: 12148095 [TBL] [Abstract][Full Text] [Related]
4. Safety of CO(2)- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency. Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; Cage D; Bissonette EA; Koenig KG; Ayers CR; McConnell K AJR Am J Roentgenol; 2001 May; 176(5):1305-11. PubMed ID: 11312200 [TBL] [Abstract][Full Text] [Related]
5. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464 [TBL] [Abstract][Full Text] [Related]
6. [Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency]. Dinkel HP; Hoppe H; Baumgartner I; Do DD; Triller J Rofo; 2002 Jan; 174(1):56-61. PubMed ID: 11793285 [TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?]. Schönefeld E; Höwler S; Osada N; Torsello G Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540 [TBL] [Abstract][Full Text] [Related]
8. Contrast nephrotoxicity and iso-osmolar contrast agents: implications of NEPHRIC. Nicholson T; Downes M Clin Radiol; 2003 Sep; 58(9):659-60. PubMed ID: 12943635 [No Abstract] [Full Text] [Related]
9. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Erley CM; Bader BD; Berger ED; Tuncel N; Winkler S; Tepe G; Risler T; Duda S Nephrol Dial Transplant; 2004 Oct; 19(10):2526-31. PubMed ID: 15280530 [TBL] [Abstract][Full Text] [Related]
11. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG AJR Am J Roentgenol; 1991 Jul; 157(1):59-65. PubMed ID: 2048540 [TBL] [Abstract][Full Text] [Related]
12. Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment. Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; McGraw JK; Ayers C Radiology; 1999 Mar; 210(3):663-72. PubMed ID: 10207465 [TBL] [Abstract][Full Text] [Related]
13. The use of gadolinium for arterial interventions. Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688 [TBL] [Abstract][Full Text] [Related]
14. Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity. Goldfarb S; Spinler S; Berns JS; Rudnick MR Invest Radiol; 1993 Nov; 28 Suppl 5():S7-10; discussion S11-2. PubMed ID: 8282507 [TBL] [Abstract][Full Text] [Related]
15. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Matchett WJ; McFarland DR; Russell DK; Sailors DM; Moursi MM Radiology; 1996 Nov; 201(2):569-71. PubMed ID: 8888260 [TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media. Spinler SA; Goldfarb S Ann Pharmacother; 1992 Jan; 26(1):56-64. PubMed ID: 1606346 [TBL] [Abstract][Full Text] [Related]